Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
207.10
+0.47 (0.23%)
Nov 11, 2025, 3:54 PM EST - Market open
Natera Market Cap
Natera has a market cap or net worth of $28.58 billion as of November 11, 2025. Its market cap has increased by 93.92% in one year.
Market Cap
28.58B
Enterprise Value
27.98B
1-Year Change
93.92%
Ranking
Category
Stock Price
$207.10
Market Cap Chart
Since July 2, 2015, Natera's market cap has increased from $1.10B to $28.58B, an increase of 2,495.60%. That is a compound annual growth rate of 36.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2025 | 28.52B | 36.46% |
| Dec 31, 2024 | 20.90B | 177.68% |
| Dec 29, 2023 | 7.53B | 91.96% |
| Dec 30, 2022 | 3.92B | -55.62% |
| Dec 31, 2021 | 8.83B | 3.98% |
| Dec 31, 2020 | 8.50B | 225.28% |
| Dec 31, 2019 | 2.61B | 202.62% |
| Dec 31, 2018 | 863.10M | 78.55% |
| Dec 29, 2017 | 483.40M | -21.19% |
| Dec 30, 2016 | 613.40M | 13.59% |
| Dec 31, 2015 | 540.00M | -50.96% |
| Jul 2, 2015 | 1.10B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 887.73B |
| Johnson & Johnson | 462.92B |
| AbbVie | 394.06B |
| UnitedHealth Group | 291.92B |
| AstraZeneca | 267.87B |
| Novartis AG | 243.29B |
| Merck & Co. | 223.31B |
| Abbott Laboratories | 220.12B |